AMD shares are posting nearly double-digit gains today and are attempting to reverse the downward trend that has persisted since late 2023 and early 2024. For the first time since October 2024, the stock has broken above the 200-session exponential moving average (EMA200, red line).
Shares of Advanced Micro Devices (AMD.US) are up more than 9% today, and the company is the top S&P 500 performer.
- The stock was upgraded by Piper Sandler's analysts, lifting the stock price target up to $140 per share. Analysts warned that AMD is watching very big business optimism in GPU segment, seeing AI megatrend as a major catalyst.
- AMD shares are rebounding after a 57% YoY data center revenue jump, boosted by rising AI demand and deeper ties with Microsoft and Meta. Positive sentiments on Wall Street, fresh $6B buyback, billion-dollar Middle East AI chip deals are also very strong catalysts.
Few days ago, AMD and OpenAI introduced also new MI400 chips addressed for AI processing. Market may see overall company development as a start of gaining more significant share in global GPU vs the Nvidia.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appAdvanced Micro Devices (AMD.US), D1 interval
Source: xStation5
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
